HBSP (USA)
-
Cuántos subordinados directos
Neilson, Gary L.; Wulf, Julie M.Article HBS-R1204HKnowledge and CommunicationSi los altos ejecutivos se sienten cada vez más presionados por el tiempo, por qué iban a agregar más a sus platos? Puede sonar contradictorio, pero la investigación de Booz & Company Gary L. Neilson y Harvard Business School profesor Julie Wulf muestra que en los últimos 20 años esperanza media del CEO de control, medida por el número de informes directos, se ha duplicado. Se encuentra en casi el 10 por hoy. Esto le da relevancia fresca a una pr...Starting at €8.20
-
Alibaba Group (Spanish version)
Wulf, Julie M.Case HBS-710S18StrategyDiscusses how Alibaba Group successfully managed new business ventures to become a leader in China's online marketplaces. Students follow Alibaba Group's transition from a startup to a multibusiness firm with over 15,000 employees in just over a decade. They analyze the evolving dynamics of internal competition and cooperation among Alibaba Group's subsidiaries. Students are also asked to address Alibaba Group's strategy, the role of its corporat...Starting at €8.20
-
BlackRock (B): Acquire MLIM - Teaching Note
Gulati, Ranjay; Gilson, Stuart C.; Sesia, AldoTeaching Note HBS-719431-EStrategyTeaching note to case 717405 and 717485Starting at €0.00
-
Organization and Strategy at Millennium (A)
Wulf, Julie M.; Waggoner, ScottCase HBS-710415-ELeadership and People ManagementThis case examines Millennium's strategic and organizational responses to the rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder and CEO Mark Levin moved the firm downstream away from research and towards drug development and commercialization, while narrowing horizontal breadth from over a dozen therapeutic classes to ju...Starting at €8.20
-
Organization and Strategy at Millennium (B)
Wulf, Julie M.; Waggoner, ScottCase HBS-710418-EStrategyThis case examines Millennium's strategic and organizational responses to the rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder CEO Mark Levin moved the firm downstream away from research and towards drug development and commercialization, while narrowing horizontal breadth from over a dozen therapeutic classes to just t...Starting at €5.74
-
Technical Note (Spanish version)
Gilson, Stuart C.Case HBS-204S14FinanceThis case provides a technical overview of different valuation techniques for use in valuing companies in corporate restructuring. Techniques covered include adjusted present value, WACC, capital cash flow, and discounted cash flow valuation. Specific numerical examples are provided.Starting at €8.20
-
How Many Direct Reports
Neilson, Gary L.; Wulf, Julie M.Article HBS-R1204H-EIf senior executives are feeling ever more pressed for time, why would they add more to their plates? It might sound counterintuitive, but research by Booz & Company's Gary L. Neilson and Harvard Business School professor Julie Wulf shows that over the past 20 years the CEO's average span of control, measured by the number of direct reports, has doubled. It stands at almost 10 today. This gives fresh relevance to a perennial question for senior l...Starting at €8.20
-
Constellation Brands' Investment in Canopy Growth: Aiming High
Gilson, Stuart C.; Abbott, Sarah L.Case HBS-220044-EFinanceIn 2017, Constellation Brands, the U.S. based beverage company, acquired a 9.9% equity interest in the Canadian marijuana company, Canopy Growth. In 2018, Constellation announced a subsequent investment in Canopy-taking its ownership interest to 37%. However, Canopy's performance had been volatile and net losses had increased since the investment. In an effort to get into the cannabis market early, had Constellation Brands been too early?Starting at €8.20
-
Chase Manhattan Corp.: The Making of America's Largest Bank
Gilson, Stuart C.; Escalle, Cedric X.Case HBS-298016-EFinanceChase Bank and Chemical Bank intend to merge, producing the largest commercial bank in the United States, the fourth largest in the world. Projected financial benefits under the merger reflect significant planned reduction in operating costs, including 17Starting at €8.20
-
School Specialty, Inc.
Gilson, Stuart C.; Mugford, KristinCase HBS-214084-EFinanceSet in 2013, School Specialty was a financially troubled supplier of educational products to primary and secondary schools in the United States. The company planned to file Chapter 11 in order to address its excessive debt load, but needed to arrange debtor-in-possession financing to provide liquidity while in bankruptcy. The company has received a financing proposal from its existing term loan lender that includes some aggressive and unusual fea...Starting at €8.20